U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06915142) titled 'A Phase II Clinical Study of HRS-7058 in Combination With Antitumor Drugs in Patients With Advanced Malignant Tumour' on April 01.
Brief Summary: This study is a multicentre, open phase II clinical study of dose escalation, dose extension and efficacy extension of HRS-7058 in combination with antitumor drugs in subjects with advanced malignant tumour. To evaluate the safety, tolerability and efficacy of HRS-7058 in combination with antitumor drugs.
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Advanced Malignant Tumour
Intervention:
DRUG: HRS-7058 + SHR-1316
HRS-7058 + SHR-1316
DRUG: HRS-7058 + SHR-1316...